Survey
* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project
Cancer Care Engineering: Studies on Oxidative Damage and SNPs Lisa M. Kamendulis, PhD James E. Klaunig, PhD Indiana University 1 Question: Is oxidative stress status altered in individuals with polyps or colorectal cancer? What Modulates Oxidative Stress? Dietary and lifestyle influences high fat diet, alcohol, smoking, etc. increased levels Antioxidants decreased levels Approach • Whole blood collected and processed from 235 individuals for: – Comet Analysis (Direct and Oxidative DNA damage) – Total Antioxidant Capacity (TEAC) – Focused SNP analysis Inflammation Sources: Mitochondria Endothelial Cells Immune Cells (including microglia) Peroxisomes Metabolism (P450) (Xenobiotics) Antioxidants GSH, Vitamin E, VitC, SOD, Catalase, etc • Pro-oxidants H2O2, O2-, HO, 1O2 Samples: – 104 controls – 92 polyps – 27 colon cancer • 11 with 1 follow-up; 4 with 2 follow-up – 12 rectal cancer – • 3 with 1 follow-up; 2 with 2 follow-up SNPs evaluated only on samples from the initial visit 2 Question: Is oxidative stress status altered in individuals with polyps or colorectal cancer? • Comet data (235 samples analyzed): Group n Control Polyp Colon Cancer Rectal Cancer Colorectal Cancer 104 92 27 12 39 Direct DNA Damage 1.13 ± 0.53 1.14 ± 0.54 1.16 ± 0.58 0.93 ± 0.33 1.09 ± 0.52 Oxidative DNA Damage 1.48 ± 0.68 1.45 ± 0.57 1.77 ± 0.59* 1.82 ± 0.55* 1.79 ± 0.55* *p < 0.05 • Total Antioxidant Capacity (TEAC) Data (235 samples analyzed): Group Control Polyp Colon Cancer Rectal Cancer Colorectal Cancer n 104 92 27 12 15 Antioxidant Capacity 5.62 ± 0.47 5.71 ± 0.50 5.72 ± 0.43 5.87 ± 0.54 5.77 ± 0.46 *p < 0.05 3 Question: Do differences exist in SNPs for oxidative stress and damage, and selective genes associated with colorectal cancer? SNPs evaluated (129 samples analyzed) • Oxidative Stress – – – – – Catalase SOD2 NOS3 GSTP GSTM1 • DNA Damage/Repair – – – – APEX1 XRCC OGG1 TP53 • Inflammation – IL-6 – IL-8 – PTGS2 (COX2) • Vitamin D Status – VDR – CASR – CYP24A1 • Metabolism – CYP1A2 – CYP3A4 4 Question: Do differences exist in SNPs for oxidative stress and damage, and selective genes associated with colorectal cancer? APEX1 (I64V) II CASR (A986S) Catalase (-262 C/T) IV VV AA AS SS -TT Control (57) 100 0 0 84 16 0 58 40 2 2 7 91 9 32 60 11 0 30 59 37 56 7 0 7 Polyp (52) 100 0 0 67 31 2 62 33 6 0 4 96 4 42 54 14 3 41 41 52 40 8 0 12 88 Colon Ca (15) 100 0 0 80 13 7 80 20 0 0 20 80 27 20 53 14 0 50 36 33 53 13 0 33 67 Rectal Ca (5) 0 80 20 0 40 40 20 0 0 100 0 0 33 67 20 40 40 0 0 100 -- -- -- -- -- NN NK KK AA AG GG CC CG GG 60 40 PTGS2 (Ex10 +837) PTGS2 -- EE ED DD SS SC CC -- -- -- 0 II IL6 (5') -- OGG1 (S326C) -TT GSTP1 (I105V) CC CT NOS3 (E298D) -- GSTM1 (N173K) TT IL8 (5') -- CC CT CYP24A1 (intron) AA AG GG GG GT 100 0 -- CYP1A2 (5') -- SOD (A16V) TP53 (P72R) VV VA AA RR RP PP IV VV -- -- -- AA AG GG CC CG GG VDR (intron) -- -- 93 XRCC (Q399R) -- RR RQ QQ AA AT TT GG GT TT CC CG GG CC CT TT AA AG GG AA AG GG CC CG GG CC CT TT CC CT TT Control (57) 22 51 27 42 47 11 58 37 5 7 32 61 39 46 16 19 58 23 65 25 11 35 42 23 51 44 5 Polyp (52) 22 51 27 37 54 10 48 48 4 4 44 52 40 46 13 25 46 29 46 44 10 31 63 6 44 50 6 Colon Ca (15) 20 40 40 53 40 7 87 7 7 20 33 47 40 40 20 20 53 27 53 33 13 40 40 20 27 47 27 Rectal Ca (5) 60 20 20 60 20 80 20 60 20 20 60 20 60 40 0 40 60 40 0 80 0 0 20 0 60 40 0 5 Question: Do differences exist in SNPs for oxidative stress and damage, and selective genes associated with colorectal cancer? Control Polyp Colon Cancer Rectal Cancer Control Polyp Colon Cancer Rectal Cancer Control Polyp Colorectal Cancer Rectal Cancer n 57 52 15 5 GSTM1 (N173K) (%) Al-1 AL-2 Both Null 11 30 0 59 14 41 3 41 14 50 0 36 0 33 0 67 n 57 52 15 5 COX2 (-1195) (%) Al-1 AL-2 Both 7 61 32 4 52 44 20 47 33 20 20 60 n 57 52 15 5 APEX1 (I64V) (%) Al-1 AL-2 Both 100 0 0 100 0 0 100 0 0 100 0 0 • GSTM1 null shown to be protective, % null population decreases in colorectal cancer • Polymorphism in promoter region of COX2 reported to change transcriptional activity. Not previously reported in colon cancer • I64V amino acid change, function unknown. No differences observed in this population. 6 Next Steps • Complete sample and data analysis – 3 additional samples collected – SNPs completed on all 235 samples • Data Analysis/Evaluation – SNP tools – Correlation analysis with other endpoints 7